Palliative care

• Health & Medicine

New test could help select the best treatment for bowel cancer patients

A new test could help patients with advanced bowel cancer get the best treatment for their disease. A new test could help patients with advanced bowel cancer get the best treatment for their disease.

11 February 2016

• Health & Medicine

Skin rash predicts survival benefit from latest lung cancer drug

Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday). Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday).

16 October 2012

• Health & Medicine

New Guide Can Predict Patients' Survival

A new way of predicting how long terminally ill cancer patients have to live, has been devised by Cancer Research UK-funded research. A new way of predicting how long terminally ill cancer patients have to live, has been devised by Cancer Research UK-funded research.

9 November 2010

• Health & Medicine

New funding for British research into cancer care

Two grants have been awarded from a programme of nearly Ј5 million to boost research into supportive and palliative care for British cancer patients. Two grants have been awarded from a programme of nearly Ј5 million to boost research into supportive and palliative care for British cancer patients.

12 June 2006